Protalix BioTherapeutics, Inc. Selling, General and Administrative Expense
Protalix BioTherapeutics, Inc. (PLX) reported Selling, General and Administrative Expense of $3.11 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-12
- Protalix BioTherapeutics, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $3.11M, a 18.56% increase year-over-year.
- Protalix BioTherapeutics, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $3.05M, a 17.21% increase year-over-year.
- Protalix BioTherapeutics, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $3.53M, a 17.57% increase year-over-year.
- Protalix BioTherapeutics, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $2.93M, a 12.87% increase year-over-year.
- Protalix BioTherapeutics, Inc. selling, general and administrative expense for fiscal 2025 was $11.68M, a 4.19% decline from fiscal 2024.
- Protalix BioTherapeutics, Inc. selling, general and administrative expense for fiscal 2024 was $12.19M, a 18.49% decline from fiscal 2023.
- Protalix BioTherapeutics, Inc. selling, general and administrative expense for fiscal 2023 was $14.96M, a 27.73% increase from fiscal 2022.
- Protalix BioTherapeutics, Inc. selling, general and administrative expense for fiscal 2022 was $11.71M, a 8.00% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.11M 10-Q · filed 2026-08-12 | $6.16M 10-Q · filed 2026-08-12 | $9.69M derived: sum of 3 quarters · filed 2026-08-12 | $12.62M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $3.05M 10-Q · filed 2026-05-13 | $6.58M derived: sum of 2 quarters · filed 2026-05-13 | $9.51M derived: sum of 3 quarters · filed 2026-05-13 | $12.13M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $6.46M derived: sum of 2 quarters · filed 2026-03-18 | $9.08M derived: sum of 3 quarters · filed 2026-08-12 | $11.68M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $2.93M 10-Q · filed 2025-11-13 | $5.55M derived: sum of 2 quarters · filed 2026-08-12 | $8.16M 10-Q · filed 2025-11-13 | $11.15M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $2.62M 10-Q · filed 2026-08-12 | $5.23M 10-Q · filed 2026-08-12 | $8.23M derived: sum of 3 quarters · filed 2026-08-12 | $10.82M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $2.60M 10-Q · filed 2026-05-13 | $5.60M derived: sum of 2 quarters · filed 2026-05-13 | $8.20M derived: sum of 3 quarters · filed 2026-05-13 | $11.68M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $5.59M derived: sum of 2 quarters · filed 2026-03-18 | $9.08M derived: sum of 3 quarters · filed 2026-03-18 | $12.19M 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | $2.60M 10-Q · filed 2025-11-13 | $6.08M derived: sum of 2 quarters · filed 2025-11-13 | $9.19M 10-Q · filed 2025-11-13 | $13.34M derived: sum of 4 quarters · filed 2026-03-18 | ||||
| 2024-06-30 | $3.48M 10-Q · filed 2025-08-14 | $6.60M 10-Q · filed 2025-08-14 | $10.74M derived: sum of 3 quarters · filed 2026-03-18 | $14.41M derived: sum of 4 quarters · filed 2026-03-18 | ||||
| 2024-03-31 | $3.12M 10-Q · filed 2025-05-09 | $7.26M derived: sum of 2 quarters · filed 2026-03-18 | $10.93M derived: sum of 3 quarters · filed 2026-03-18 | $14.96M derived: sum of 4 quarters · filed 2026-03-18 | ||||
| 2023-12-31 | $4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $7.81M derived: sum of 2 quarters · filed 2026-03-18 | $11.84M derived: sum of 3 quarters · filed 2026-03-18 | $14.96M 10-K · filed 2026-03-18 | ||||
| 2023-09-30 | $3.67M 10-Q · filed 2024-11-14 | $7.70M derived: sum of 2 quarters · filed 2024-11-14 | $10.82M 10-Q · filed 2024-11-14 | $13.91M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | $4.03M 10-Q · filed 2024-08-14 | $7.15M 10-Q · filed 2024-08-14 | $10.24M derived: sum of 3 quarters · filed 2025-03-17 | $13.09M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | $3.12M 10-Q · filed 2024-05-10 | $6.21M derived: sum of 2 quarters · filed 2025-03-17 | $9.06M derived: sum of 3 quarters · filed 2025-03-17 | $11.67M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $5.95M derived: sum of 2 quarters · filed 2025-03-17 | $8.56M derived: sum of 3 quarters · filed 2025-03-17 | $11.71M 10-K · filed 2025-03-17 | ||||
| 2022-09-30 | $2.85M 10-Q · filed 2023-11-06 | $5.46M derived: sum of 2 quarters · filed 2023-11-06 | $8.61M 10-Q · filed 2023-11-06 | $12.08M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-06-30 | $2.61M 10-Q · filed 2023-08-07 | $5.76M 10-Q · filed 2023-08-07 | $9.23M derived: sum of 3 quarters · filed 2024-03-14 | $12.19M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | $3.15M 10-Q · filed 2023-05-04 | $6.62M derived: sum of 2 quarters · filed 2024-03-14 | $9.57M derived: sum of 3 quarters · filed 2024-03-14 | $12.74M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2021-12-31 | $3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $6.42M derived: sum of 2 quarters · filed 2024-03-14 | $9.59M derived: sum of 3 quarters · filed 2024-03-14 | $12.73M 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | $2.95M 10-Q · filed 2022-11-14 | $6.13M derived: sum of 2 quarters · filed 2022-11-14 | $9.26M 10-Q · filed 2022-11-14 | $12.21M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $3.17M 10-Q · filed 2022-08-15 | $6.31M 10-Q · filed 2022-08-15 | $9.26M derived: sum of 3 quarters · filed 2023-02-27 | $12.08M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $3.14M 10-Q · filed 2022-05-16 | $6.09M derived: sum of 2 quarters · filed 2023-02-27 | $8.90M derived: sum of 3 quarters · filed 2023-02-27 | $11.10M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $5.77M derived: sum of 2 quarters · filed 2023-02-27 | $7.96M derived: sum of 3 quarters · filed 2023-02-27 | $11.15M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $2.82M 10-Q · filed 2021-11-15 | $5.01M derived: sum of 2 quarters · filed 2021-11-15 | $8.20M 10-Q · filed 2021-11-15 | $11.21M derived: sum of 4 quarters · filed 2022-03-31 | ||||
| 2020-06-30 | $2.19M 10-Q · filed 2021-08-16 | $5.38M 10-Q · filed 2021-08-16 | $8.39M derived: sum of 3 quarters · filed 2022-03-31 | $10.98M derived: sum of 4 quarters · filed 2022-03-31 | ||||
| 2020-03-31 | $3.19M 10-Q · filed 2021-05-14 | $6.20M derived: sum of 2 quarters · filed 2022-03-31 | $8.79M derived: sum of 3 quarters · filed 2022-03-31 | $10.86M derived: sum of 4 quarters · filed 2022-03-31 | ||||
| 2019-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $5.60M derived: sum of 2 quarters · filed 2022-03-31 | $7.67M derived: sum of 3 quarters · filed 2022-03-31 | $9.90M 10-K · filed 2022-03-31 | ||||
| 2019-09-30 | $2.59M 10-Q · filed 2020-10-29 | $4.66M derived: sum of 2 quarters · filed 2020-10-29 | $6.88M 10-Q · filed 2020-10-29 | $9.06M derived: sum of 4 quarters · filed 2021-03-30 | ||||
| 2019-06-30 | $2.07M 10-Q · filed 2020-08-10 | $4.30M 10-Q · filed 2020-08-10 | $6.47M derived: sum of 3 quarters · filed 2021-03-30 | $10.56M derived: sum of 4 quarters · filed 2021-03-30 | ||||
| 2019-03-31 | $2.23M 10-Q · filed 2020-06-01 | $4.40M derived: sum of 2 quarters · filed 2021-03-30 | $8.49M derived: sum of 3 quarters · filed 2021-03-30 | $10.65M derived: sum of 4 quarters · filed 2021-03-30 | ||||
| 2018-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $6.26M derived: sum of 2 quarters · filed 2021-03-30 | $8.42M derived: sum of 3 quarters · filed 2021-03-30 | $10.92M 10-K · filed 2021-03-30 | ||||
| 2018-09-30 | $4.09M 10-Q · filed 2019-11-07 | $2.64M 10-Q · filed 2018-11-07 | $6.25M derived: sum of 2 quarters · filed 2019-11-07 | $8.74M 10-Q · filed 2019-11-07 | $7.29M 10-Q · filed 2018-11-07 | $12.09M derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-06-30 | $2.16M 10-Q · filed 2019-08-08 | $4.66M 10-Q · filed 2019-08-08 | $8.00M derived: sum of 3 quarters · filed 2020-03-12 | $10.84M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | $2.50M 10-Q · filed 2019-05-06 | $5.84M derived: sum of 2 quarters · filed 2020-03-12 | $8.68M derived: sum of 3 quarters · filed 2020-03-12 | $11.49M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $6.18M derived: sum of 2 quarters · filed 2020-03-12 | $8.99M derived: sum of 3 quarters · filed 2020-03-12 | $11.53M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | $2.84M 10-Q · filed 2019-03-18 | $5.65M derived: sum of 2 quarters · filed 2019-03-18 | $8.19M 10-Q · filed 2019-03-18 | $11.33M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | $2.81M 10-Q · filed 2019-03-18 | $5.35M 10-Q · filed 2019-03-18 | $8.49M derived: sum of 3 quarters · filed 2019-03-18 | $10.51M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | $2.54M 10-Q · filed 2019-03-18 | $5.68M derived: sum of 2 quarters · filed 2019-03-18 | $7.69M derived: sum of 3 quarters · filed 2019-03-18 | $9.90M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | $3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $5.16M derived: sum of 2 quarters · filed 2019-03-18 | $7.36M derived: sum of 3 quarters · filed 2019-03-18 | $9.36M 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | $2.01M 10-Q · filed 2017-11-08 | $4.22M derived: sum of 2 quarters · filed 2017-11-08 | $6.21M 10-Q · filed 2017-11-08 | $7.51M derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2016-06-30 | $2.21M 10-Q · filed 2017-08-09 | $4.20M 10-Q · filed 2017-08-09 | $5.49M derived: sum of 3 quarters · filed 2018-03-06 | $7.66M derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2016-03-31 | $2.00M 10-Q · filed 2017-05-10 | $3.29M derived: sum of 2 quarters · filed 2018-03-06 | $5.45M derived: sum of 3 quarters · filed 2018-03-06 | $7.45M derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2015-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $3.46M derived: sum of 2 quarters · filed 2018-03-06 | $5.46M derived: sum of 3 quarters · filed 2018-03-06 | $7.28M 10-K · filed 2018-03-06 | ||||
| 2015-09-30 | $2.16M 10-Q · filed 2016-11-09 | $2.25M 10-Q · filed 2015-11-09 | $4.16M derived: sum of 2 quarters · filed 2016-11-09 | $5.99M 10-Q · filed 2016-11-09 | $6.26M 10-Q · filed 2015-11-09 | $7.92M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $2.00M 10-Q · filed 2016-08-08 | $2.09M 10-Q · filed 2015-08-10 | $3.82M 10-Q · filed 2016-08-08 | $4.00M 10-Q · filed 2015-08-10 | $5.76M derived: sum of 3 quarters · filed 2017-03-16 | $7.77M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | $1.82M 10-Q · filed 2016-05-09 | $1.91M 10-Q · filed 2015-05-07 | $3.76M derived: sum of 2 quarters · filed 2017-03-16 | $5.77M derived: sum of 3 quarters · filed 2017-03-16 | $7.34M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $3.95M derived: sum of 2 quarters · filed 2017-03-16 | $5.52M derived: sum of 3 quarters · filed 2017-03-16 | $9.23M 10-K · filed 2017-03-16 | $9.66M 10-K · filed 2015-03-12 | |||
| 2014-09-30 | $2.01M 10-Q · filed 2015-11-09 | $3.58M derived: sum of 2 quarters · filed 2015-11-09 | $7.29M 10-Q · filed 2015-11-09 | $9.28M derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2014-06-30 | $1.57M 10-Q · filed 2015-08-10 | $5.28M 10-Q · filed 2015-08-10 | $7.26M derived: sum of 3 quarters · filed 2016-03-08 | $9.04M derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2014-03-31 | $3.71M 10-Q · filed 2015-05-07 | $5.70M derived: sum of 2 quarters · filed 2016-03-08 | $7.48M derived: sum of 3 quarters · filed 2016-03-08 | $9.66M derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2013-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $3.77M derived: sum of 2 quarters · filed 2016-03-08 | $5.95M derived: sum of 3 quarters · filed 2016-03-08 | $8.05M 10-K · filed 2016-03-08 | $8.38M 10-K · filed 2015-03-12 | |||
| 2013-09-30 | $1.78M 10-Q · filed 2014-11-10 | $3.96M derived: sum of 2 quarters · filed 2014-11-10 | $6.07M 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | $2.18M 10-Q · filed 2014-08-07 | $4.29M 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | $2.10M 10-Q · filed 2014-05-08 | |||||||
| 2012-12-31 | $9.76M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |